Kyoko Imanaka-Yoshida
Overview
Explore the profile of Kyoko Imanaka-Yoshida including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
163
Citations
2995
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nakayama T, Ogo K, Sugano Y, Yokokawa T, Kanamori H, Ikeda Y, et al.
Open Heart
. 2025 Mar;
12(1).
PMID: 40081931
Background: Among patients with dilated cardiomyopathy (DCM), myocardial inflammation and fibrosis are risk factors for poor clinical outcomes. Here, we investigated the combined prognostic value of these two factors, as...
2.
Katoh D, Senga Y, Mizutani K, Maruyama K, Yamakawa D, Yamamuro T, et al.
iScience
. 2025 Feb;
28(2):111756.
PMID: 39925433
Lymphatic vessels are required for the clearance of excess fluid and immune cells from inflamed tissue, making the regulation of lymphangiogenesis an important area of research. Although the positive regulatory...
3.
Omori T, Maruyama K, Ohta-Ogo K, Hatakeyama K, Ishibashi-Ueda H, Onoue K, et al.
Circ J
. 2024 Nov;
89(1):120-129.
PMID: 39496392
Background: The effects of myocarditis after mRNA COVID-19 vaccination (mCV) on myocardial tissue, and the association between cardiomyocyte injury and clinical presentation, are not fully understood. Methods And Results: We...
4.
Omori K, Takada A, Toyomasu Y, Tawara I, Shintoku C, Imanaka-Yoshida K, et al.
Curr Issues Mol Biol
. 2024 Sep;
46(9):9674-9685.
PMID: 39329927
The lung is a major dose-limiting organ for radiation therapy (RT) for cancer in the thoracic region, and the clarification of radiation-induced lung damage (RILD) is important. However, there have...
5.
Makino M, Moriwaki K, Fujimoto N, Kirii Y, Mizutani H, Goto T, et al.
Circ Cardiovasc Imaging
. 2024 Jul;
17(12):e016905.
PMID: 39082131
No abstract available.
6.
Nakamori S, Amyar A, Fahmy A, Ngo L, Ishida M, Nakamura S, et al.
Circulation
. 2024 May;
150(1):7-18.
PMID: 38808522
Background: Current cardiovascular magnetic resonance sequences cannot discriminate between different myocardial extracellular space (ECSs), including collagen, noncollagen, and inflammation. We sought to investigate whether cardiovascular magnetic resonance radiomics analysis can...
7.
Hirose K, Hori Y, Ozeki M, Motooka D, Hata K, Tahara S, et al.
Hum Pathol
. 2024 Feb;
145:48-55.
PMID: 38367816
Venous malformations (VMs) are the most common vascular malformations. TEK and PIK3CA are the causal genes of VMs, and may be involved in the PI3K/AKT pathway. However, the downstream mechanisms...
8.
Yamaguchi S, Minamide N, Imai H, Ikeda T, Watanabe M, Imanaka-Yoshida K, et al.
EMBO J
. 2024 Feb;
43(5):868-885.
PMID: 38351385
Lymphatic vessel development studies in mice and zebrafish models have demonstrated that lymphatic endothelial cells (LECs) predominantly differentiate from venous endothelial cells via the expression of the transcription factor Prox1....
9.
Hattori Y, Hasegawa M, Iino T, Imanaka-Yoshida K, Sudo A
Biomedicines
. 2023 Aug;
11(8).
PMID: 37626753
Despite its widespread existence, there are relatively few drugs that can inhibit the progression of osteoarthritis (OA). Syndecan-4 (SDC4) is a transmembrane heparan sulfate proteoglycan that modulates cellular interactions with...
10.
Matsui K, Torii S, Hara S, Maruyama K, Arai T, Imanaka-Yoshida K
Int J Mol Sci
. 2023 Jun;
24(12).
PMID: 37373332
Adverse ventricular remodeling after myocardial infarction (MI) is progressive ventricular dilatation associated with heart failure for weeks or months and is currently regarded as the most critical sequela of MI....